首页> Blood: The Journal of the American Society of Hematology> Targeting CD45 with an Amanitin Antibody-Drug Conjugate Effectively Depletes Human HSCs and Immune Cells for Transplant Conditioning

Targeting CD45 with an Amanitin Antibody-Drug Conjugate Effectively Depletes Human HSCs and Immune Cells for Transplant Conditioning

导出原文传递

翻译打印收藏纠错

作者： Palchaudhuri, Rahul ^[1] ; Pearse, Bradley R. ; Proctor, Jennifer L. ; Hyzy, Sharon L. ; Aslanian, Sharon ; McDonough, Sean M. ; Sarma, Ganapathy ; Brooks, Melissa L. ; Bhat, Anjali ; Ladwig, Danielle ; McShea, Molly A. ; Kallen, Nathan M. ; Li, Qing ; Panwar, Rajiv ; Dushime, Junia ; Sawant, Pranoti ; Adams, Hillary L. ; Falahee, Patrick C. ; Lamothe, Tahirih L. ; Gabros, Andrew D. ; Kien, Lena ; Gillard, Geoff ; McDonagh, Charlotte F. ; Boitano, Anthony E. ; Cooke, Michael P.

作者单位： Magenta Therapeut, Cambridge, MA USA ^[1]

发布时间 2020-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood

2018年Novel Treatment Appr期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting CD45 with an Amanitin Antibody-Drug Conjugate Effectively Depletes Human HSCs and Immune Cells for Transplant Conditioning

Blood

相似文献

Blood

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting CD45 with an Amanitin Antibody-Drug Conjugate Effectively Depletes Human HSCs and Immune Cells for Transplant Conditioning

Blood

相似文献

Blood

相关期刊

检索历史清除